Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine dose comparison for post-cesarean pain control
IRCT20230417057937N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ketamine in postoperative pain (3 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Pain. Started Aug 2023; status: completed.
02
Drugs
ketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20230417057937N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230417057937N1.